Impairment -General Health questionnaire), multiplied by the Brazilian GDP per capita. For DC estimation, patients were identifying by ICD-10 code and procedures for BC treatment were obtained from national databases (Inpatient Information System, SIH/SUS and Outpatient Information System, SIA/SUS). The clinical impact of BC was analyzed by Disability Adjusted Life Years (DALYs). Years of life lost (YLL) was calculated based on the life expectancy (Brazilian Institute of Geography and Statistics) and BC mortality (SIM/DATASUS). Age-weighting and 5% discount rate were used. Years lived with disability (YLD) were calculated through an incidence perspective based on disability weights presented on Global Burden of Disease Study (2013) and incidence from Brazilian National Institute of Cancer. All analysis was based on 2014 data. ReSultS: In 2014, BC resulted in a loss of 27,738 years due to the premature death and 12,402 due to disabilities, resulting in 40,140 DALYs. Direct cost attribute to BC treatment was US$29,879,165, whereas indirect cost was estimation was of US$ 76,996,523. ConCluSionS: Despite the relative low incidence and age of patients affected, BC results in a relevant clinical and economic burden to the Brazilian society. The development of strategies related to prevention and early diagnosis is essential.
self-examination (50%) the chance of longer delay was higher (OR= 3.2, 95%CI:1.6-6.1). ConClusions: GPs play an important role in the early detection of melanoma lesions, propagation of self-examination, awareness raising in the recognition of signs. The vigilance of GPs is especially important in case of patients with higherrisk and disorders in less visible places.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.